AI Could Save $425 Billion By Closing The Signal Gap
Google’s Gemini 3.5 Pro AI model delay has led to a $425 billion market cap loss, highlighting the impact of AI development setbacks on investor confidence.
Scribe Therapeutics Announces Pricing Of Upsized Initial Public Offering
Scribe Therapeutics announced it has priced its upsized initial public offering at a higher range, raising additional capital for its gene editing technology.